Log in to search using one of your social media accounts:

 

Correction to: Report from the 2nd Cardiovascular Outcome Trial (CVOT) Summit of the Diabetes and Cardiovascular Disease (D & CVD) EASD Study Group

Following publication of the original article [1], author Antonio Ceriello requested that a correction be published in relation to his affiliations. His correct affiliations have been updated in this erratum. Thi...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Tags: Correction Source Type: research

Related Links:

New classes of drugs to treat type 2 diabetes are continually being developed and marketed. The FDA has issued guidance to the pharmaceutical industry that newer hypoglycemic agents should not be associated with unacceptable increases in cardiovascular risk. To date, five trials have assessed specific cardiovascular endpoints for these newer agents. Empagliflozin and liraglutide have been found to improve cardiovascular outcomes.
Source: Journal of the American Academy of Physician Assistants - Category: Primary Care Tags: Pharmacology Consult Source Type: research
Gagnum V, Saeed M, Stene LC, Leivestad T, Joner G, Skrivarhaug T. Low Incidence of End-Stage Renal Disease in Childhood-Onset Type 1 Diabetes Followed for Up to 42 Years. Diabetes Care 2017, in press.
Source: The Journal of Pediatrics - Category: Pediatrics Authors: Tags: Current Best Evidence Source Type: research
COPENHAGEN (Reuters) - The world's largest diabetes drugmaker Novo Nordisk on Thursday presented the first successful data from a final-stage study for a pill it hopes will transform the diabetes market.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news
Every stakeholder needs to prepare in time for the waves of technological innovation transforming the medical sector and the pharma industry. Regulators and decision-makers with the right policies could do the most for a swift and smooth transit into the future. New Zealand’s government recognized the challenges and made important steps to facilitate the adoption of digital health. Responsible governments prepare their citizens for technological changes With the spread of social media and other disruptive technologies, such as artificial intelligence, health sensors, robotics, 3D printing or nanotechnology, healthcar...
Source: The Medical Futurist - Category: Information Technology Authors: Tags: Healthcare Policy digital health digital health strategy future health policy Innovation new zealand policy-making regulations technology Source Type: blogs
Introduction: In 2030 diabetes will cause one amputation every 20 seconds. Currently 10 to 20% of all diabetic patients develop infected foot ulcers that recur 40% of the time within one year, even when adequately treated by antibiotics, angioplasty or bypass. Therefore, factors other than infection and peripheral artery disease must be incriminated in wound healing in diabetic patients. The identification of those factors is the subject of our study.Methodology: A retrospective study done at CHU-NDS (Centre Hospitalier Notre Dame De Secours) included all patients with infected diabetic ulcers between 2012 and 2017. Age wa...
Source: The Journal of Infection in Developing Countries - Category: Infectious Diseases Source Type: research
A new study examines the possible relationship between TSH levels, sudden cardiac death, total mortality, and CVD outcomes.Clinical Endocrinology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Diabetes & Endocrinology Journal Article Source Type: news
SGLT2 inhibitors create new management challenges for anesthesiologists. What are the unique considerations for diabetic patients taking these agents perioperatively?Anesthesia &Analgesia
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news
Analyst, 2018, Accepted Manuscript DOI: 10.1039/C7AN01872J, Critical ReviewVini Singh, Sadagopan Krishnan Diabetes is a complex immune disorder that requires extensive medical care beyond glycemic control. Recently, the prevalence of diabetes, particularly type 1 diabetes (T1D), has significantly increased from 5% to... The content of this RSS Feed (c) The Royal Society of Chemistry
Source: RSC - Analyst latest articles - Category: Chemistry Authors: Source Type: research
Medtronic CareLink iPro Therapy Management Software, MMT-7340 The CareLink iPro Therapy Management Software (model, MMT-7340) is intended to be used by a healthcare professional (HCP) with the iPro2 CGM System and provides upload support for the iPro2 Recorder. The CareLink iPro software is used to upload glucose sensor data stored on a recording device, capture BG meter readings through manual entry or wired-upload, retrospectively calibrate sensor data, and provide retrospective reports of continuous glucose information. The reports generated by the CareLink iPro software are intended for use by healthcare professionals ...
Source: Medical Device Recalls - Category: Medical Devices Source Type: alerts
CONCLUSIONS: Compared to the overall EUROASPIRE results in Europe, Belgian CHD patients seem to do slightly better. However, tackling obesity, physical inactivity, hypertension and psychosocial distress remains an important challenge in the management of coronary patients. PMID: 29458303 [PubMed - as supplied by publisher]
Source: Acta Cardiologica - Category: Cardiology Tags: Acta Cardiol Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Endocrinology | Heart | Study